Pentoxifylline (McKesson Contract Packaging)
Welcome to the PulseAid listing for the Pentoxifylline drug offered from McKesson Contract Packaging. This Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | McKesson Contract Packaging |
NON-PROPRIETARY NAME: | Pentoxifylline |
SUBSTANCE NAME: | PENTOXIFYLLINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-01-30 |
END MARKETING DATE: | 0000-00-00 |
Pentoxifylline HUMAN PRESCRIPTION DRUG Details:
Item Description | Pentoxifylline from McKesson Contract Packaging |
LABELER NAME: | McKesson Contract Packaging |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(mg/1) |
START MARKETING DATE: | 2012-01-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76237-225_6b902d5e-1526-4f80-bb31-57c1b4e5a4f5 |
PRODUCT NDC: | 76237-225 |
APPLICATION NUMBER: | ANDA074425 |
Other PENTOXIFYLLINE Pharmaceutical Manufacturers / Labelers: